Profile and investment
| Fund type | SICAV |
|---|---|
| Investment style (stocks) | Market Cap: Large Investment Style: Blend |
| Income treatment | -- |
| Morningstar category | Sector Equity Healthcare |
| Launch date | 10 Dec 2021 |
| Price currency | EUR |
| Domicile | Luxembourg |
| ISIN | MEDTE |
| Manager & start date |
| Pricing frequency | Daily |
|---|---|
| Fund size | -- As of Sep 30 2025 |
| Share class size | 1.58m GBP As of Sep 30 2025 |
| Net expense ratio | -- |
| Initial charge | -- |
| Max annual charge | -- |
| Exit charge | -- |
| Min. initial investment | -- |
| Min. additional investment | -- |
| Min. regular investment | -- |
| UK ISA | -- |
| Available for sale | Austria, France, Germany, Italy, Luxembourg, Netherlands, Spain, Switzerland |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 44.89% | 13.24% | 0.00% | 13.24% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc ALNY:NSQ | +33.07% | 2.87% | |
| argenx SE ARGX:BRU | +16.39% | 2.77% | |
| IQVIA Holdings Inc IQV:NYQ | -11.44% | 2.56% | |
| Genmab A/S GMAB:CPH | +18.51% | 2.54% | |
| Hoya Corp 7741:TYO | +42.41% | 2.50% | |
| Per cent of portfolio in top 5 holdings: 13.24% |
Asset type
| Cash | 0.00% |
| UK stock | -- |
| Non-UK stock | -- |
| UK bond | -- |
| Non-UK bond | -- |
| Other | 0.00% |
Top 5 sectors
| Healthcare | 98.04% |
| Basic Materials | 1.96% |
Top 5 regions
Regions data is unavailable
Sector and region weightings are calculated using only long position holdings of the portfolio.
